Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Alternate Health Corp. is Ranked 4th on Canadian Securities Exchange in its First Year

Alternate Health Corp.
Posted on: 21 Sep 17

PR Newswire

TORONTO, Sept. 21, 2017

TORONTO, Sept. 21, 2017 /PRNewswire/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, today announced that the Company has been ranked fourth amongst its peers on the Canadian Securities Exchange's CSE 25 Index.

"As the exchange has grown rapidly in terms of trading volumes and market capitalization, it is appropriate that we give market participants a benchmark that monitors the performance of our largest and most liquid issues," says Richard Carleton, CEO of the Canadian Securities Exchange.  "As the 'Exchange for Entrepreneurs', we are proud of their success in the Canadian capital markets."

A subgroup of the CSE Composite Index, the new CSE25 index includes the top 25 securities by market capitalization contained in the composite index. Together, these companies account for over 50% of the weighting in the Composite Index and typically are stocks that attract the most trading volume.

"We are proud of our inclusion in the CSE25 Index and to be recognized among the top five performers on the Canadian Securities Exchange," says Dr. Michael Murphy, CEO of Alternate Health. "This is a sign of the Company's strong momentum as we push forward with our goal to be the global authority on scientific and clinical support for medical cannabis in regulated markets".

About Alternate Health Corp.
Alternate Health Corp. (CSE:AHG, OTCQB:AHGIF) is an international medical cannabis company that uses best in class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. The company is strategically positioned in all facets of the medical cannabis value chain through the innovative integration of proprietary technology and know-how, acquisitions and partnerships, deep direct knowledge of, and experience with improving patient outcomes, and management expertise.

Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders. The Company is headquartered in San Antonio, Texas, with operations in Los Angeles and Toronto.

For more information about Alternate Health Corp., visit

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements

SOURCE Alternate Health Corp.

PR Newswire

Last updated on: 21/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.